Look, I'm just trying to help youse fellas out. The approval is already priced into this stock. Any hint of troubles, and we can expect a modest fall.
But don't kid yourselves - there is no upside here. At least not on any Ropren announcement. The market considers it a done deal.
However, I have my suspicions that the Russians are growing a backbone. They won't approve a drug so that the Americans can use them as guinea pigs.
